Renishaw plc Receives Consensus Rating of “Hold” from Brokerages (LON:RSW)
Renishaw plc (LON:RSW) has received a consensus rating of “Hold” from the seven ratings firms that are currently covering the company, American Banking News reports. Five analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is GBX 1,834.29 ($31.15).
Shares of Renishaw plc (LON:RSW) opened at 1783.00 on Wednesday. Renishaw plc has a one year low of GBX 1470.00 and a one year high of GBX 2240.00. The stock’s 50-day moving average is GBX 1664. and its 200-day moving average is GBX 1829.. The company’s market cap is £1.298 billion.
The company also recently declared a dividend, which is scheduled for Monday, October 20th. Investors of record on Wednesday, September 17th will be given a dividend of GBX 29.87 ($0.51) per share. This represents a yield of 1.64%. The ex-dividend date of this dividend is Wednesday, September 17th.
RSW has been the subject of a number of recent research reports. Analysts at Numis Securities Ltd upgraded shares of Renishaw plc to an “add” rating in a research note on Wednesday, July 23rd. They now have a GBX 1,750 ($29.72) price target on the stock. Separately, analysts at N+1 Singer reiterated a “hold” rating on shares of Renishaw plc in a research note on Wednesday, July 23rd. They now have a GBX 1,690 ($28.70) price target on the stock. Finally, analysts at Investec upgraded shares of Renishaw plc to a “buy” rating in a research note on Tuesday, July 22nd. They now have a GBX 1,810 ($30.74) price target on the stock.
Renishaw plc is a metrology company. The Company is engaged in the design, manufacture and sale of advanced precision metrology and inspection equipment together with products for the healthcare sector, including Raman spectroscopy systems, dental systems, molecular diagnostic equipment and neurosurgical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.